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1. Introduction 
The use of bifunctional reagents for the preparation 
of inter- or intramolecular cross-links in proteins has 
been extensively used, particularly for information 
about inter-residue distances in proteins, for evaluating 
the importance of secondary forces in the stabilisation 
of protein structure, and for studying protein sub-unit 
interactions [ I] 
In extending my previous work on the modification 
of the amino groups of insulin with acylating agents 
[2] , it was of interest to study the reaction of insulin 
with bifunctional acylating agents in order to obtain 
more information about the moiecular architecture of 
the insulin molecule. It is pertinent to examine such 
derivatives in relation to the tertiary structure of in- 
sulin as shown in the crystallographic analysis of 
rhombohedral 2Zn insulin crystals [3] and to examine 
the effect such modification might have on the hypo- 
glycaemic action of the hormone. 
Bifunctional acylating agents have not been widely 
used for controlled cross-linking in proteins. Schnell 
and Zahn [4] have utilized the nitrophenyl esters of 
dicarboxylic acids to cross-link collagen. However, 
recent work [2] suggests that the use of the 
highly activated hydroxysuccinimide esters developed 
by Anderson et al. [5] for peptide synthesis, allows 
the formation of N-acyl derivatives of insulin in high 
yields using a 1: 1 molar ratio of reagent to protein. 
They also appear to be highly selective for amino 
groups. By these means we have prepared a pure intra- 
molecular cross-linked derivative of insulin by reaction 
with bis-hydroxysuccinimide succinate. 
2. Materials and methods 
Bis-hydroxysuccinimide succinate (m.p. 260” dec.) 
North-Holland Publishing Company - Amsterdam 
was prepared by a modification of the method of 
Schnell and Zahn [4] using N-hydroxysuccinimide 
instead of p-nitrophenol. The derivative was analytical- 
ly pure. 
Bovine insulin, essentially free of proinsulin, was 
dissolved in anhydrous dimethylformamide at a con- 
centration of 0.1% w/v. Redistilled anhydrous tri- 
ethylamine was added to the insulin solution at a con- 
centration of 0.05% v/v. The mixture was then 
treated with bishydroxysuccinimide succinate (1 mole 
equivalent) in aliquots in dimethylformamide solution. 
The reaction mixture was left overnight. The dimethyl- 
formamide was removed on a rotary evaporator at 
40” under reduced pressure and the product exten- 
sively dialysed against 0.01 M NH,OH and lyophilised. 
The modified insulin preparation was subjected to 
DEAE-Sephadex chromatography in 7 M urea buffers 
as previously described [ 21 . 
GlyA1 -hemi-succinyl-insulin was prepared by treat- 
ment of insulin with succinyl chloride in dimethyl- 
formamide solution (pract.) followed by isolation of 
the relevant isomer by chromatography on DEAE- 
Sephadex. 
Oxidative sulfitolysis was performed by the method 
of Bailey and Cole [6] and the S-sulphonates separated 
by thin layer electrophoresis on cellulose plates using 
4 M urea, 2.4 M formic acid buffer, 50 V/cm, i = 30 
mA, t = 40 min. The derivatives were visualised by 
the Pauly stain. 
The blood sugar assays were determined in rabbits 
previously fasted for 24 hr prior to an i.v. injection of 
insulin and derivatives. Each value was the mean of 
six animals and the initial mean value was taken as 
100%. Insulin was injected at a dose of 0.5 IU/kg 
(0.0185 mg/kg) and the derivatives at a dose of 0.0185 
mg/kg. The activity of the insulin and derivatives was 
determined from the blood glucose level after 30 min. 
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3. Results 
Chromatography of the crude products of the 
reaction of insulin with bis-hydroxysuccinimide 
succinate is shown,in fig. 1 Fractions loo-142 were 
rechromatographed under exactly the same conditions 
until a pure disubstituted insulin derivative was isolated 
as judged by isoelectric focussing [7]. Lindsay and 
Shall [2] have previously shown that disubstituted 
A’ , B29 -insulin derivatives are eluted in these fractions. 
End group analysis [8] of the derivative showed 
that the gly*’ and 1~s~~~ amino functions of insulin 
were modified. Treatment of the derivative with 
TPCK-treated trypsin [9] showed the presence of 
0.1 1 mole of alanine per mole of insulin, suggesting 
that the lys B29 group of insulin was modified to the 
extent of 89%. 
Oxidative sulfitolysis of the derivative and electro- 
phoresis of the products (fig. 2) proved that the deri- 
vative was intramolecularly cross-linked. The deriva- 
tive was also chromatographed on a Sephadex G-50 
column using 7 M urea buffers [lo] and eluted in the 
same position as insulin under these conditions and 
accordingly the material was designated as gly*‘- 
lysB29-succinyl-insulin (fig. 3). 
Biological testing of this material by the rabbit 
blood-sugar assay showed that it had approximately 
60% of the biological activity of insulin assayed under 
the same conditions. This result was not significantly 
different from the activity of glyA1 -hemi-succinyl- 
insulin which also showed 60% of the biological 
activity of native insulin. 
4. Discussion 
Zahn and Meienhofer [ 1 l] studied the cross-linking 
of insulin with 1,5-difluoro-2,4_dinitrobenzene and 
demonstrated intramolecular cross-linking of gly*’ 
and lys B29 occurred at a concentration of 0.03% 
w/v. They concluded that these two groups in insulin 
must be = 5 a apart for such a derivative to be fa- 
voured. Howeve;, a pure product was not isolated 
from these studies. We are able to report on the isola- 
tion of a pure intramolecular cross-linked insulin 
which retains a substantial amount of the biological 
activity of insulin. 
Although uncertainties exist about the exact inter- 
pretation of the electron density map of insulin in the 
region of the terminal part of the B-chain [3] , it seems 
certain that the glyA1 and 1~s~~~ amino groups are 
= 5-8 A apart in insulin crystals. Attempts are being 
made to crystallise this derivative to obtain further 
information about the effect the succinyl bridge has 
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Fig. 1. DEAE-Sephadex chromatography of the reaction products of the modified insulin preparation (400 mg) using a column 
(2.5 cm X 40 cm) equilibrated with 7 M urea, 0.01 M Tris-HCl, 0.10 M NaCl at pH 7.30. The flow rate was 54 ml/hr and 9.0 ml 
fractions were collected. (G--_): absorbance at 277 nm. (L-A): moles of NaCl applied as a salt gradient. 
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Fig. 2. Thin layer electrophoresis of sulfitolysed insulin and 
derivatives. (I) Sulfitolysed insulin. (2) glyAl-lysB29-suc- 
cinyl-insulin. (3) Sulfitolysed glyAl-hemi-succinyl-insulin. 
(4) Sultitolysed glyAl-JysB29-succinyl insulin. 
had on inter-atomic contacts in this area of the mole- 
cule. The linking of the terminal part of the B-chain 
by the succinyl bridge may help to evaluate the role 
of certain salt-bridges uch as the A2’ , B2 * interaction 
in the stabilisation of the molecule. 
It is of interest to compare the biological activity 
of gly Al-lysB29-succinyl-insulin with the activity of 
the acetoacetyl insulins previously prepared [2] The 
activity of the cross-linked derivative is somewhat 
lower than the size of the succinyl group would in- 
dicate. This is not due to the diffent method of assay 
as acetyl insulins give exactly the same results when 
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Fig. 3. Schematic representation of glyAl-lysB29-succinyl-in- 
sulin after the model of Zahn [ 161. 
assayed by the mouse convulsion or the rabbit blood- 
sugar assay. It would imply that the rigidity of the 
succinyl bridge distorts the ‘active site’ of insulin. The 
activity of glyA 1 -hemi-succinyl-insulin might be ex- 
plained by repulsions caused by the introduction of a 
charged carboxyl group. 
Gly Al -1y sB29- succinyl-insulin can also be considered 
as a crude ‘proinsulin-like’ model. Although the con- 
necting link joints the A’ and B29 amino groups and 
not the amino group of A’ and the carboxyl residue 
of B3’ as in proinsulin, B29 and B3’ occupy very 
close positions in the rhombohedral insulin crystal. 
The profound influence of the connecting peptide 
of proinsulin on the ribosomal synthesis of native in- 
sulin has been demonstrated in vitro by Steiner and 
Clark [ 121 who reduced and subsequently reoxidised 
proinsulin and proved that the correct pairing of 
cysteine residues had occurred. However, it is possible 
to imagine that a smaller connecting bridge between 
glycine Al and the terminal part of the B-chain of the 
insulin molecule is sufficient to ensure such correct 
pairing, particularly as the sequences of the connecting 
peptides of porcine [13], bovine [14], and human 
proinsulin [ 151 have shown that the connecting pep- 
tides which join the Al and B30 residues in the in- 
sulin molecule are highly species variable, varying in 
both their length and in many amino acid substitutions. 
Recombination studies are in progress on a series of 
intramolecularly cross-linked insulins of varying chain 
lengths in order to test this hypothesis. 
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